<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

5 min read

Q319 US Hemostats and Sealants Market Recap: All Companies Post Gains

1/6/20 12:16 PM

Q319 Hemo-1The US market for Hemostats and Sealants grew +5.6% YoY in Q319, a continued deceleration from +6.4% YoY in Q219, with fibrin sealants and absorbable hemostats driving the increase.

As reported in SmartTRAK’s Financial Dashboard, every manufacturer in the Hemostats and Sealants market experienced revenue growth in Q319. Leading the way was Becton Dickinson (BD), with IntegraEthicon and Baxter all posting strong gains. The US Hemostats and Sealants market was up +5.6% YoY with all competitors posting gains for the quarter. Sealants continued their solid growth, up +6.5% YoY, with fibrin sealants leading the way. Absorbable hemostats resumed their leadership, contributing to the +5.1% YoY growth to...

Among the many topics covered in the complete, comprehensive Q319 US Hemostats and Sealants Market Recap* are:

  • Ethicon’s Market Dominance Slips
  • Absorbable Hemostats Take The Lead
  • Biologic Sealants Continue To Rebound
  • Important Events and Trials in Q319

The US Hemostats and Sealants market increased to $XXX Blurred in Q219, up +5.6% YoY. All competitors posted gains for the quarter. Sealants continued their solid growth, up +6.5% YoY, with fibrin sealants leading the way. Absorbable hemostats resumed their leadership, contributing to the +5.1% YoY growth to $XXX Blurred.

In Q319, Ethicon continued to lead the overall US Hemostat and Sealants market, up + 4.1% YoY with $XXX Blurred in revenue and 47.0% share, rebounding from 40.7% share in Q219 as it recovers from its stumble in Q219. Baxter grew...


Read the complete, comprehensive Q319 US Hemostats and Sealants Market Recap including news, financial data, charts, company revenues and shares, plus insightful analysis from our team of experts*...

*The entire unedited article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.

Request SmartTRAK Subscription Info

 

 

 

 

Topics: Wound Care

Doug Devens
Written by Doug Devens

20 years of diverse medical device experience, including leading companies 3M, Coloplast and Boston Scientific, along with emerging companies. Leadership experience in product development, including championing the process for voice of customer and concept feedback sessions with key thought leaders.

    Recent Articles